A specialist venture capital fund writing first checks into medtech and biotech — built by subject matter experts who have lived the research, not just read about it.
Diagnostics, devices, and therapeutics for a market long underbuilt and underfunded — from fertility to menopause to chronic conditions.
Interfaces, measurement, and modulation. Where deep neuroscience meets engineering to treat what was once untreatable.
Hardware, software, and biology that move the standard of care. Technical risk we can underwrite from the bench up.
First-check conviction for technical founders building in the largest, most active life-sciences ecosystem in the world.
A bridge into a deep-tech and aging-health market with world-class research and a growing appetite for global impact.
A scientist-operator who spent a decade at the lab bench before moving to the cap table — pairing genuine technical judgment with the discipline of how companies actually get built and advised.
If you're a seed-stage founder in medtech, femtech, neurotech, or biotech across the US or Japan, we want to hear from you. We read every deck, move quickly, and can engage with the science directly — no translation layer required.
Send your deck → Seed stage · US & JapanWe're partnering with a small group of accredited US investors for Fund I. If you want exposure to early-stage health and life-science innovation alongside a scientifically-credentialed manager, let's talk.
Accredited US investors only